1. Home
  2. RXST

RXST

RxSight Inc.

Logo RxSight Inc.

Health Care

Biotechnology: Electromedical & Electrotherapeutic Apparatus

Nasdaq

as 04-12-2024 4:00pm EST

$
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

RxSight Inc is a commercial-stage medical technology company dedicated towards improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The Company operates and manages its business in one reportable segment, the research and development, manufacture and sale of light adjustable lenses and related capital equipment.

Founded: 1997 Country:
United States
United States
Employees: N/A City: ALISO VIEJO
Market Cap: 2.0B IPO Year: 2021
Target Price: $51.14 AVG Volume (30 days): 417.7K
Analyst Decision: Strong Buy Number of Analysts: 7
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: -1.41 EPS Growth: N/A
52 Week Low/High: $17.00 - $58.21 Next Earning Date: 05-07-2024
Revenue: $89,077,000 Revenue Growth: 81.77%
Revenue Growth (this year): 50.64% Revenue Growth (next year): 32.42%

Share on Social Networks: